For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

The Wistar Institute

USPTO Granted Patents = 246

% Expired Patents = 6.5

CIPO Patents = 2

EPO Patents = 10

Trademarks = 3

Forward Citations = 3,369

Loading Chart...

Loading Chart...

250 inventors (with patents filed for the assignee):

David B Weiner (43 out of 196 patents)

Hildegund C J Ertl (17 out of 19 patents)

Hilary Koprowski (13 out of 27 patents)

4. Meenhard Herlyn (12 out of 12 patents)

5. Paul M Lieberman (11 out of 11 patents)

6. Troy E Messick (10 out of 10 patents)

7. Kar Muthumani (10 out of 13 patents)

8. Louise C Showe (10 out of 11 patents)

9. William Valentine Williams (10 out of 28 patents)

10. Garry Robert Smith (9 out of 33 patents)

11. George C Prendergast (8 out of 27 patents)

12. Jose R Conejo-Garcia (8 out of 12 patents)

13. Ami Patel (8 out of 10 patents)

14. Thanos D Halazonetis (8 out of 13 patents)

15. Giovanni Rovera (8 out of 8 patents)

Core Competencies:

Cancer Vaccines

Immune Response

Zika Virus

Ebola Virus

DNA Constructs

Adenoviral Vectors

Myeloid-Derived Suppressor Cells

Tumor Treatment

HSP70 Inhibitors

Filovirus Antigens

Melanoma Treatment

Vaccine Compositions

246 patents: Sort by Forward Citations

1. 12616753 - HSP70 inhibitors and methods of using same (2026-05-05),

2. 12595293 - Anti-Follicle Stimulating Hormone Receptor Antibodies (2026-04-07),

3. 12544433 - Melanoma Canine Vaccine Compositions and Methods of Use Thereof (2026-02-10),

4. 12419945 - Vaccines against Zika virus (2025-09-23),

5. 12404307 - Methods and compositions for use of recombinant bacterial effector proteins as anti-inflammatory agents (2025-09-02),

6. 12391959 - Adenoviral vectors comprising partial deletions of E3 (2025-08-19),

7. 12390525 - Constructs for enhancing immune responses (2025-08-19),

8. 12390521 - Canine distemper vaccines and methods of treatment using the same (2025-08-19),

9. 12384826 - Methods and compositions for treating cancer (2025-08-12),

10. 12357683 - Vaccines against Nipah virus, and methods of using same (2025-07-15),

11. 12344642 - Variant survivin vaccine for treatment of myeloma (2025-07-01),

12. 12296001 - DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV) (2025-05-13),

13. 12295990 - Use of lactoferrin for generating myeloid-derived suppressor cells (2025-05-13),

14. 12290561 - Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same (2025-05-06),

15. 12281084 - Acetyl-CoA synthetase 2 (ACSS2) inhibitors and methods using same (2025-04-21),

Company Overview

The Wistar Institute, located in Philadelphia, PA, is a prominent biomedical research institution specializing in cancer vaccines and immunotherapy. It focuses on advancing the understanding of immune responses to various diseases, including cancer, Zika virus, and Ebola virus. The institute employs innovative technologies such as DNA constructs and adenoviral vectors to develop therapeutic strategies. Wistar's research also explores the role of myeloid-derived suppressor cells in tumor treatment, contributing significantly to the field of cancer immunology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

246 Patents

#12 in Philadelphia, PA

#72 in Pennsylvania

#1,740 in US

#3,533 in the World

Philadelphia, PA, United States of America

The Wistar Institute

Forward Citations = 3,369

250 inventors:

David B Weiner (43 out of 196 patents)

Hildegund C J Ertl (17 out of 19 patents)

Hilary Koprowski (13 out of 27 patents)

4. Meenhard Herlyn (12 out of 12 patents)

5. Paul M Lieberman (11 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Wistar Institute. Retrieved from https://idiyas.com/company/wistar-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…